Simplex Trading
NRXP icon

Simplex Trading’s NRX Pharmaceuticals NRXP Stock Holding History

Simplex Trading’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.7K Buy
+800
New +$1.61K ﹤0.01% 8433
2025
Q4 		– Sell
-600
Closed -$1K – 9582
2025
Q3 		$1K Sell
600
-4,900
-89% -$14K ﹤0.01% 8847
2025
Q2 		$17K Buy
5,500
+4,900
+817% +$12.3K ﹤0.01% 6910
2025
Q1 		$1K Buy
+600
New +$1.69K ﹤0.01% 8264
2023
Q1 		– Sell
-100
Closed -$1K – 9781
2022
Q4 		$1K Buy
+100
New +$1.01K ﹤0.01% 8874
2022
Q2 		– Sell
-2,040
Closed -$49K – 10714
2022
Q1 		$49K Sell
2,040
-1,540
-43% -$50.1K ﹤0.01% 7157
2021
Q4 		$171K Buy
+3,580
New +$258K ﹤0.01% 5414

Other funds holding NRXP

BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BFG
Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Simplex Trading's NRXP Position: Q3 2025 in Review

Simplex Trading sold out of NRX Pharmaceuticals (NRXP) in Q3 2025, closing a stake of 690 shares — an estimated $1.98K sold.

Simplex Trading first reported a position in NRXP in Q4 2021 and held it in 8 quarters. The position peaked at $55K in Q4 2021. 24 funds tracked by Wall St. Rank hold NRXP as of Q3 2025.

  • Simplex Trading reported no remaining NRX Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 690 NRX Pharmaceuticals shares in Q3 2025, an estimated $1.98K.
  • Simplex Trading first reported a position in NRX Pharmaceuticals in Q4 2021 and held it in 8 quarters.
  • Simplex Trading's NRX Pharmaceuticals position peaked at $55K in Q4 2021.
  • 24 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.